Cargando…
Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin in db/db diabetic mice
Alteration in renin‐angiotensin system (RAS) has been implicated in the pathophysiology of diabetic kidney disease (DKD). The deleterious actions of angiotensin II (Ang II) could be antagonized by the formation of Ang‐(1–7), generated by the actions of angiotensin‐converting enzyme 2 (ACE2) and nepr...
Autores principales: | Alawi, Laale F., Emberesh, Sana E., Owuor, Brenda A., Chodavarapu, Harshita, Fadnavis, Rucha, El‐Amouri, Salim S., Elased, Khalid M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002536/ https://www.ncbi.nlm.nih.gov/pubmed/32026607 http://dx.doi.org/10.14814/phy2.14364 |
Ejemplares similares
-
Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion
por: Chodavarapu, Harshita, et al.
Publicado: (2013) -
Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension
por: Alawi, Laale F., et al.
Publicado: (2021) -
Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice
por: Pedersen, Kim Brint, et al.
Publicado: (2015) -
Type 2 Diabetes Leads to Axon Initial Segment Shortening in db/db Mice
por: Yermakov, Leonid M., et al.
Publicado: (2018) -
Resistin Production from Adipose Tissue Is Decreased in db/db Obese Mice, and Is Reversed by Rosiglitazone
por: Ye, Hongying, et al.
Publicado: (2013)